A detailed history of Russell Investments Group, Ltd. transactions in United Therapeutics Corp stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 65,182 shares of UTHR stock, worth $24.7 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
65,182
Previous 62,508 4.28%
Holding current value
$24.7 Million
Previous $19.9 Million 17.31%
% of portfolio
0.03%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$311.04 - $363.55 $831,720 - $972,132
2,674 Added 4.28%
65,182 $23.4 Million
Q2 2024

Aug 08, 2024

SELL
$228.26 - $319.04 $203,151 - $283,945
-890 Reduced 1.4%
62,508 $19.9 Million
Q1 2024

May 08, 2024

SELL
$210.76 - $249.51 $3.48 Million - $4.13 Million
-16,533 Reduced 20.68%
63,398 $14.6 Million
Q4 2023

Feb 05, 2024

SELL
$214.88 - $256.94 $7.3 Million - $8.73 Million
-33,986 Reduced 29.83%
79,931 $17.6 Million
Q3 2023

Nov 13, 2023

SELL
$211.82 - $248.24 $512,816 - $600,989
-2,421 Reduced 2.08%
113,917 $25.7 Million
Q2 2023

Aug 10, 2023

SELL
$205.19 - $232.99 $3.38 Million - $3.83 Million
-16,450 Reduced 12.39%
116,338 $25.7 Million
Q1 2023

May 09, 2023

BUY
$212.99 - $276.17 $2.61 Million - $3.39 Million
12,263 Added 10.17%
132,788 $29.7 Million
Q4 2022

Feb 08, 2023

SELL
$205.95 - $280.43 $8 Million - $10.9 Million
-38,834 Reduced 24.37%
120,525 $33.5 Million
Q3 2022

Nov 04, 2022

BUY
$203.3 - $244.17 $11.8 Million - $14.1 Million
57,828 Added 56.96%
159,359 $33.4 Million
Q2 2022

Jul 29, 2022

BUY
$174.81 - $241.14 $3.01 Million - $4.15 Million
17,194 Added 20.39%
101,531 $23.9 Million
Q1 2022

May 05, 2022

SELL
$166.16 - $213.96 $11.3 Million - $14.6 Million
-68,235 Reduced 44.72%
84,337 $15.1 Million
Q4 2021

Jan 21, 2022

SELL
$184.32 - $216.08 $13.6 Million - $15.9 Million
-73,567 Reduced 32.53%
152,572 $33 Million
Q3 2021

Nov 08, 2021

SELL
$179.86 - $214.88 $6.78 Million - $8.1 Million
-37,687 Reduced 14.28%
226,139 $41.7 Million
Q2 2021

Aug 04, 2021

SELL
$170.47 - $211.93 $10.6 Million - $13.2 Million
-62,337 Reduced 19.11%
263,826 $47.2 Million
Q1 2021

May 10, 2021

SELL
$153.94 - $174.85 $8.57 Million - $9.73 Million
-55,644 Reduced 14.57%
326,163 $54.4 Million
Q4 2020

Feb 08, 2021

SELL
$101.87 - $151.79 $6.22 Million - $9.26 Million
-61,013 Reduced 13.78%
381,807 $57.5 Million
Q3 2020

Nov 09, 2020

BUY
$99.9 - $121.13 $4.76 Million - $5.77 Million
47,633 Added 12.05%
442,820 $44.7 Million
Q2 2020

Aug 05, 2020

BUY
$92.74 - $125.82 $10.6 Million - $14.4 Million
114,069 Added 40.58%
395,187 $47.6 Million
Q1 2020

May 06, 2020

BUY
$79.39 - $115.35 $8.09 Million - $11.8 Million
101,944 Added 56.9%
281,118 $26.9 Million
Q4 2019

Jan 29, 2020

BUY
$78.31 - $95.34 $1.73 Million - $2.11 Million
22,081 Added 14.06%
179,174 $15.7 Million
Q3 2019

Nov 01, 2019

SELL
$74.85 - $85.99 $1.68 Million - $1.93 Million
-22,431 Reduced 12.49%
157,093 $12.7 Million
Q2 2019

Aug 09, 2019

SELL
$76.06 - $120.81 $354,972 - $563,820
-4,667 Reduced 2.53%
179,524 $13.9 Million
Q1 2019

May 13, 2019

SELL
$107.15 - $126.84 $1.37 Million - $1.63 Million
-12,820 Reduced 6.51%
184,191 $21.6 Million
Q4 2018

Feb 11, 2019

SELL
$101.4 - $128.73 $1.22 Million - $1.54 Million
-11,985 Reduced 5.73%
197,011 $20.8 Million
Q3 2018

Oct 26, 2018

BUY
$113.81 - $129.46 $3.25 Million - $3.7 Million
28,542 Added 15.82%
208,996 $26.5 Million
Q2 2018

Aug 08, 2018

SELL
$101.14 - $118.31 $8.04 Million - $9.41 Million
-79,541 Reduced 30.59%
180,454 $20.1 Million
Q1 2018

May 11, 2018

SELL
$107.21 - $151.94 $684,857 - $970,592
-6,388 Reduced 2.4%
259,995 $29.2 Million
Q4 2017

Feb 06, 2018

SELL
$118.58 - $151.28 $10.1 Million - $12.9 Million
-85,340 Reduced 24.26%
266,383 $39.8 Million
Q3 2017

Nov 07, 2017

BUY
$114.6 - $136.81 $40.3 Million - $48.1 Million
351,723
351,723 $41.2 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17.3B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.